<DOC>
	<DOCNO>NCT02007837</DOCNO>
	<brief_summary>Hypertensive disorder pregnancy ( HDP ) 50.000 death every year one major cause maternal mortality worldwide , especially low middle income country . This trial aim determine whether daily dose combine low-dose aspirin , calcium , vitamin D3 , folic acid vitamin B12 pregnancy reduces incidence pregnancy-induced hypertension woman risk . Secondary tertiary objective include maternal neonatal outcome .</brief_summary>
	<brief_title>Prospects Prevention Pregnancy-induced Hypertension Preeclampsia Trial</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Hypertension , Pregnancy-Induced</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<criteria>&lt; 16 week gestation 18 year age , Intention subsequent antenatal visit delivery clinic . Can receive text message phone phone proxy . A moderate high risk ( &gt; 20 % ) develop PIH Preexisting hypertension hypertension 20 week gestation . Likely noncompliance protocol view treat physician Comorbidity interfere protocol Known contraindication Investigational Product component</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>pregnancy induce hypertension</keyword>
	<keyword>gestational hypertension</keyword>
	<keyword>pre-eclampsia</keyword>
	<keyword>preeclampsia</keyword>
	<keyword>hypertensive disorder pregnancy</keyword>
</DOC>